financetom
Market
financetom
/
Market
/
Global stocks dither, bonds steady as recession worries weigh
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Global stocks dither, bonds steady as recession worries weigh
Apr 6, 2023 8:08 AM

Global stocks drifted on Thursday and US Treasury yields hovered near multi-month lows as traders awaited crucial US jobs data that may add to mounting concerns about a global economic slowdown.

Share Market Live

NSE

As equity investors avoid strong bets, ahead of the Good Friday holiday when the market-moving monthly US non-farm payrolls report will also be released, the broad MSCI index of world stocks traded flat.

Europe's Stoxx 600 share index added 0.3%, boosted by data showing German industrial output rose significantly more than forecast in February. But recession fears weighed on US stock futures and crude oil.

US Nasdaq E-mini futures pointed to a 0.5% drop at the New York open after the tech stock benchmark slumped 1% overnight. E-mini futures for the broader S&P 500 slipped 0.1%, following Wednesday's 0.25% slide.

Also Read: Gold hits record high on weak US economic data

Following the US Federal Reserve's most aggressive cycle of interest rate hikes in decades, to battle stubbornly high inflation, traders are now positioning for the central bank to turn much more dovish.

Data overnight showed US private employers hired far fewer workers than expected in March, adding to signs from earlier in the week of a loosening labour market. The country's services sector also slowed more than expected, while earlier figures showed a stalling at factories as well.

"What we're seeing this week is those rate hikes having an impact on the broad economy for about the first time," Roger Lee, head of UK equity strategy at Investec, said. "The market is extrapolating this recent data for the conviction that there is going to be a U.S. recession imminently."

Economists polled by Reuters expect to see US employers added 240,000 new workers in March, down from 311,000 the previous month. Average earnings growth is also expected to have slowed to 4.3% year-over-year, from 4.6% in March.

Money markets now see the odds of a further quarter-point hike at the May meeting versus a pause as a coin toss. And 74 basis points of easing are priced in by year-end.

Also Read: World Bank lowers India's FY23-24 GDP growth forecast to 6.3% from 6.6% earlier

"Investors should not rush to buy the pivot, as when the Fed cuts rates, it is too late to prevent a recession," Barclays chief European equity strategist Emmanual Cau said.

Treasury yields, which move inversely to prices of the debt securities, have fallen far in recent weeks as traders added risk in bond markets instead of equities.

The yield on the 10-year note stood at around 3.29% on Thursday morning in London, sticking close to the nearly seven-month low of 3.266% reached overnight.

Germany's 10-year bund yield, a benchmark for Eurozone borrowing costs, added 2 basis points to 2.2%.

This German yield now stands far below its level of about 2.7% from early March, before the failure of two U.S. banks and Credit Suisse's rescue by UBS sparked concerns about banks lending cautiously to safeguard capital, potentially harming growth.

Also Read: China’s services activity surges to more than two-year high

The dollar index was steady against other major currencies at 101.84, bumping around a two-month low.

Spot gold slipped 0.1% from a one-year high reached on Wednesday, to $2,019 per ounce, but remained more than 2% higher for the week.

Oil was also under pressure, despite a surprise output cut decision by OPEC+ producers at the weekend. Brent crude, the global benchmark, was off 0.3% at $84.76 a barrel.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
S&P 500 Posts Weekly Drop Amid Tariff Threats; Energy Leads Broad Decline
S&P 500 Posts Weekly Drop Amid Tariff Threats; Energy Leads Broad Decline
May 26, 2025
04:46 PM EDT, 05/23/2025 (MT Newswires) -- The Standard & Poor's 500 index fell 2.6% this week, pushing the market benchmark back into the red for the year, amid a fresh round of tariff threats from the Trump administration. The market benchmark ended the week at 5,802.82. The measure is still in positive territory for May with a month-to-date gain...
Wall Street Declines After Trump's Fresh Tariff Threats; Apple Falls 3%
Wall Street Declines After Trump's Fresh Tariff Threats; Apple Falls 3%
May 26, 2025
04:59 PM EDT, 05/23/2025 (MT Newswires) -- US benchmark equity indexes declined on Friday as President Donald Trump's tariff threats against the European Union and Apple ( AAPL ) refueled concerns about a trade war. The Nasdaq Composite fell 1% at 18,737.2. The S&P 500 dropped 0.7% to 5,802.8, marking the fourth straight day of declines, while the Dow Jones...
Wall St Week Ahead-Nvidia earnings in focus as rising US yields, debt rattle markets
Wall St Week Ahead-Nvidia earnings in focus as rising US yields, debt rattle markets
May 26, 2025
* Nvidia ( NVDA ) results due on Wednesday, last of Magnificent 7 earnings * 30-year US Treasury yield tops 5% during week * After rebound, S&P 500 down over 5% from Feb record high By Lewis Krauskopf NEW YORK, May 23 (Reuters) - An earnings report from semiconductor giant and artificial intelligence bellwether Nvidia ( NVDA ) takes center...
Boundless Bio's Portfolio Adjustments and Streamlined Operations Boost Cash Runway
Boundless Bio's Portfolio Adjustments and Streamlined Operations Boost Cash Runway
May 26, 2025
04:37 PM EDT, 05/23/2025 (MT Newswires) -- Boundless Bio ( BOLD ) said late Friday it optimized its portfolio and streamlined operations, including a one-third reduction of its workforce to drive long-term value creation. The company discontinued the monotherapy and combination arms of BBI-355 candidate in Potentiate clinical trial due to toxicity concerns and a narrow therapeutic index, according to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved